0001193125-11-235645.txt : 20110829 0001193125-11-235645.hdr.sgml : 20110829 20110829171928 ACCESSION NUMBER: 0001193125-11-235645 CONFORMED SUBMISSION TYPE: 15-12G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20110829 DATE AS OF CHANGE: 20110829 EFFECTIVENESS DATE: 20110829 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IMMUCOR INC CENTRAL INDEX KEY: 0000736822 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 222408354 STATE OF INCORPORATION: GA FISCAL YEAR END: 0531 FILING VALUES: FORM TYPE: 15-12G SEC ACT: 1934 Act SEC FILE NUMBER: 000-14820 FILM NUMBER: 111063665 BUSINESS ADDRESS: STREET 1: 3130 GATWAY STREET 2: PO BOX 5625 CITY: NORCROSS STATE: GA ZIP: 30091 BUSINESS PHONE: 770 441 2051 MAIL ADDRESS: STREET 1: 3130 GATEWAY DR STREET 2: P O BOX 5625 CITY: NORCROSS STATE: GA ZIP: 30091-5625 15-12G 1 d1512g.htm FORM 15 Form 15

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 15

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION

UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR

SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number 0-14820

IMMUCOR, INC.

(Exact name of registrant as specified in its charter)

3130 Gateway Drive, P.O. Box 5625

Norcross, Georgia 30091-5625

(770) 441-2051

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

COMMON STOCK, PAR VALUE $0.10 PER SHARE

(Title of each class of securities covered by this Form)

None

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

Rule 12g-4(a)(1)

   x     

Rule 12g-4(a)(2)

   ¨     

Rule 12h-3(b)(1)(i)

   x     

Rule 12h-3(b)(1)(ii)

   ¨     

Rule 15d-6

   ¨     

Approximate number of holders of record as of the certification or notice date: One

Pursuant to the requirements of the Securities Exchange Act of 1934, Immucor, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

   
Date: August 29, 2011     By:   /s/ Philip H. Moïse
     

Name: Philip H. Moïse

Title: Executive Vice President, General Counsel and Secretary